Your browser doesn't support javascript.
loading
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.
Liu, Yang; Sethi, Nilay S; Hinoue, Toshinori; Schneider, Barbara G; Cherniack, Andrew D; Sanchez-Vega, Francisco; Seoane, Jose A; Farshidfar, Farshad; Bowlby, Reanne; Islam, Mirazul; Kim, Jaegil; Chatila, Walid; Akbani, Rehan; Kanchi, Rupa S; Rabkin, Charles S; Willis, Joseph E; Wang, Kenneth K; McCall, Shannon J; Mishra, Lopa; Ojesina, Akinyemi I; Bullman, Susan; Pedamallu, Chandra Sekhar; Lazar, Alexander J; Sakai, Ryo; Thorsson, Vésteinn; Bass, Adam J; Laird, Peter W.
Afiliação
  • Liu Y; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Sethi NS; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Hinoue T; Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
  • Schneider BG; Department of Medicine, Division of Gastroenterology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Cherniack AD; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Sanchez-Vega F; Computational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Seoane JA; Department of Medicine, and Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Farshidfar F; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgarry, Canada.
  • Bowlby R; Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z 4S6, Canada.
  • Islam M; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Kim J; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.
  • Chatila W; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Akbani R; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Kanchi RS; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Rabkin CS; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
  • Willis JE; Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Wang KK; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.
  • McCall SJ; Department of Pathology, Duke University, Durham, NC 27710, USA.
  • Mishra L; Center for Translational Research, Department of Surgery, George Washington University Cancer Center, Washington, DC 20052, USA.
  • Ojesina AI; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
  • Bullman S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Pedamallu CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Sakai R; PharmiWeb Solutions, Bracknell RG12 1QB, UK.
  • Thorsson V; Institute for Systems Biology, Seattle, WA 98109, USA. Electronic address: vesteinn.thorsson@systemsbiology.org.
  • Bass AJ; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA 02115, US
  • Laird PW; Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI 49503, USA. Electronic address: peter.laird@vai.org.
Cancer Cell ; 33(4): 721-735.e8, 2018 04 09.
Article em En | MEDLINE | ID: mdl-29622466
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Metilação de DNA / Instabilidade Cromossômica / DNA Polimerase II / Proteína 1 Homóloga a MutL / Proteínas de Ligação a Poli-ADP-Ribose / Neoplasias Gastrointestinais Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Metilação de DNA / Instabilidade Cromossômica / DNA Polimerase II / Proteína 1 Homóloga a MutL / Proteínas de Ligação a Poli-ADP-Ribose / Neoplasias Gastrointestinais Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article